切换至 "中华医学电子期刊资源库"

中华诊断学电子杂志 ›› 2025, Vol. 13 ›› Issue (02) : 73 -78. doi: 10.3877/cma.j.issn.2095-655X.2025.02.001

专题笔谈

嗅觉牵连障碍的诊断与治疗研究进展
孙振晓,1, 于相芬2   
  1. 1. 276000 临沂市疾病预防控制中心
    2. 276005 临沂市精神卫生中心精神科
  • 收稿日期:2025-02-02 出版日期:2025-05-26
  • 通信作者: 孙振晓

Research advances in the diagnosis and treatment of olfactory reference disorder

Zhenxiao Sun,1, Xiangfen Yu2   

  1. 1. Linyi Center for Disease Control and Prevention, Linyi 276000, China
    2. Department of Psychiatry,Linyi Municipal Mental Health Center, Linyi 276005, China
  • Received:2025-02-02 Published:2025-05-26
  • Corresponding author: Zhenxiao Sun
引用本文:

孙振晓, 于相芬. 嗅觉牵连障碍的诊断与治疗研究进展[J/OL]. 中华诊断学电子杂志, 2025, 13(02): 73-78.

Zhenxiao Sun, Xiangfen Yu. Research advances in the diagnosis and treatment of olfactory reference disorder[J/OL]. Chinese Journal of Diagnostics(Electronic Edition), 2025, 13(02): 73-78.

嗅觉牵连障碍(ORD)是一种持久且错误地认为自己身体存在臭味或者其他令人不愉快气味为特征的精神障碍,以导致明显的痛苦和社会功能受损为特征,常伴有牵连性思维,并试图掩盖、改变或避免自认为的气味的重复行为。该疾病的诊断应与多种躯体疾病(如牙周炎、三甲基胺尿症、直肠脓肿、肛瘘、颞叶癫痫)、社交焦虑障碍、强迫症、躯体变形障碍、妄想障碍及其他原发性精神病性障碍、心境障碍、回避型人格障碍和躯体痛苦障碍相鉴别。关于ORD的治疗,目前多为病例报道,缺乏大样本随机对照研究。治疗方式包括抗抑郁药、抗精神病药物、抗精神病药物联合抗抑郁药及心理治疗等。未来应进行多中心、随机对照研究以进一步验证各种治疗方法的疗效。本文系统回顾ORD的临床特征、诊断、鉴别诊断及治疗进展,为ORD的临床诊疗提供科学依据。

Olfactory reference disorder (ORD) is a psychiatric condition characterized by a persistent and false belief that one emits a foul or unpleasant body odour. This belief leads significant distress and impaired social functioning. It is often accompanied by referential thinking and repetitive behaviours aimed at concealing, changing or avoiding the perceived odour. Its diagnosis should be distinguished from various physical diseases (such as periodontitis, trimethylaminuria, rectal abscess, anal fistula, and temporal lobe epilepsy), social anxiety disorder, obsessive-compulsive disorder, body dysmorphic disorder, delusional disorder, and other primary psychotic disorders, mood disorder, avoidant personality disorder, and bodily distress disorder. Evidence for the treatment of ORD primarily comes from case reports, while large-sample randomized controlled studies are lacking. The treatment for ORD includes antidepressants, antipsychotic drugs, antipsychotic drugs combined with antidepressants, and psychotherapy. Multi-center, randomized controlled trials are needed to further validate the efficacy of these treatments. This paper systematically reviews the clinical characteristics, diagnosis, differential diagnosis and treatment of ORD, providing scientific evidence for the clinical diagnosis and treatment of ORD.

[1]
Thomas E,du Plessis S,Chiliza B,et al.Olfactory reference disorder:diagnosis,epidemiology and management[J].CNS Drugs,2015,29(12):999-1007.DOI:10.1007/s40263-015-0292-5.
[2]
Feusner JD,Phillips KA,Stein DJ.Olfactory reference syndrome:issues for DSM-Ⅴ[J].Depress Anxiety,2010,27(6):592-599.DOI:10.1002/da.20688.
[3]
Zhou X, Schneider SC, Cepeda SL, et al. Olfactory reference syndrome symptoms in Chinese university students:phenomenology,associated impairment,and clinical correlates[J].Compr Psychiatry,2018 (86):91-95.DOI:10.1016/j.comppsych.2018.06.013.
[4]
Potts CS.Two cases of hallucination of smell[D].Pennsylvania:University of Pennsylvania Medical Magazine,1891:266.
[5]
Pryse-Phillips W.An olfactory reference syndrome[J].Acta Psychiatr Scand,1971,47(4):484-509.DOI:10.1111/j.1600-0447.1971.tb03705.x.
[6]
World Health Organisation.ICD-11精神、行为与神经发育障碍临床描述与诊断指南[M].王振,黄晶晶,等,译.北京:人民卫生出版社,2023:71-139,159-161.
[7]
American psychiatric association.Diagnostic and statistical manual of mental disorders:DSM-Ⅳ-TR[M].Washington,DC:American Psychiatric Association,2000:131-138.
[8]
World Health Organisation.ICD-10精神与行为障碍分类临床描述与诊断要点[M].范肖东,汪向东,于欣,等,译.北京:人民卫生出版社,1993:80-81,163.
[9]
American Psychiatric Association.DSM-5精神障碍诊断与统计手册[M].张道龙,刘春雨,童慧琦,等,译.北京:北京大学出版社,2014:113-122.
[10]
Begum M,McKenna PJ.Olfactory reference syndrome:a systematic review of the World literature[J].Psychol Med,2011,41(3):453-461.DOI:10.1017/S0033291710001091.
[11]
Phillips KA,Menard W.Olfactory reference syndrome:demographic and clinical features of imagined body odor[J].Gen Hosp Psychiatry,2011,33(4):398-406.DOI:10.1016/j.genhosppsych.2011.04.004.
[12]
Prazeres AM, Fontenelle LF, Mendlowicz MV, et al. Olfactory reference syndrome as a subtype of body dysmorphic disorder[J].J Clin Psychiatry,2010,71(1):87-89.DOI:10.4088/JCP.09l05040.
[13]
Chen C,Shih YH,Yen DJ,et al.Olfactory auras in patients with temporal lobe epilepsy[J].Epilepsia,2003,44(2):257-260.DOI:10.1046/j.1528-1157.2003.25902.x.
[14]
彭慧.脑电图诊断颞叶癫痫的效果分析[J].实用医技杂志,2024,31(6):446-448.DOI:10.19522/j.cnki.1671-5098.2024.06.017.
[15]
Lochner C,Stein DJ.Olfactory reference syndrome:diagnostic criteria and differential diagnosis[J].J Postgrad Med,2003,49(4):328-331.PMID:14699232.
[16]
中国医师协会精神科医师分会躯体症状障碍研究组,胡建,马现仓.躯体痛苦障碍临床诊疗专家共识[J].中国神经精神疾病杂志,2024,50(2):65-75.DOI:10.3969/j.issn.1002-0152.2024.02.001.
[17]
Reuter J,Grocholewski A,Steil R.Associations between olfactory reerence disorder and social phobia-results of an internet-based study[J].Front Psychol,2024(7):15:1248496.DOI:10.3389/fpsyg.2024.1248496.
[18]
Das S,Sekharan L,Prasad S,et al.Olfactory reference syndrome treated with lurasidone and cognitive behavioral therapy:a case report[J].Clin Med Insights Case Rep,2022(15):11795476221139396.DOI:10.1177/11795476221139396.
[19]
Matsumoto K,Nonaka M,Arai K,et al.Cognitive behavioral therapy for a Japanese woman with olfactory reference disorder (ORD)comorbid with schizophrenia:a case study[J].PCN Rep,2024,3(1):e179.DOI:10.1002/pcn5.179.
[20]
akekita Y,Kato M, Sakai S,et al.Olfactory reference syndrome treated by blonanserin augmentation[J].Psychiatry Clin Neurosci,2011,65(2):203-204.DOI:10.1111/j.1440-1819.2010.02185.x.
[21]
Chernyak Y,Chapleau KM,Tanious SF,et al.Olfactory reference syndrome:a case report and screening tool[J].J Clin Psychol Med Settings,2021,28(2):344-348.DOI:10.1007/s10880-020-09721-9.
[22]
Dominguez RA, Puig A.Olfactory reference syndrome responds to clomipramine but not fluoxetine:a case report[J].J Clin Psychiatry,1997,58(11):497-498.DOI:10.4088/jcp.v58n1106e.
[23]
Teraishi T,Takahashi T, Suda T, et al. Successful treatment of olfactory reference syndrome with paroxetine[J].J Neuropsychiatry Clin Neurosci,2012,24(1):E24.DOI:10.1176/appi.neuropsych.11020033.
[24]
Aftab A,Latorre S.Geriatric-onset olfactory reference syndrome successfully treated with duloxetine and memantine[J].Prim Care Companion CNS Disord,2017,19(2).DOI:10.4088/PCC.16l02011 .
[25]
Yeh YW,Chen CK,Huang SY,et al.Successful treatment with amisulpride for the progression of olfactory reference syndrome to schizophrenia[J].Prog Neuropsychopharmacol Biol Psychiatry,2009,33(3):579-580.DOI:10.1016/j.pnpbp.2009.02.007.
[26]
Albers AD,Amato I,Albers MW.Olanzapine improved symptoms and olfactory function in an olfactory reference syndrome patient[J].J Neuropsychiatry Clin Neurosci,2018,30(2):164-167.DOI:10.1176/appi.neuropsych.17050096.
[27]
Miranda-Sivelo A,Bajo-Del Pozo C,Fructuoso-Castellar A.Unnecessary surgical treatment in a case of olfactory reference syndrome[J].Gen Hosp Psychiatry,2013,35(6):683.e3-e4.DOI:10.1016/j.genhosppsych.2013.06.014.
[28]
Takenoshita M, Motomura H, Toyofuku A. Olfactory reference syndrome (Halitophobia) with oral cenesthopathy treated with lowdose aripiprazole:a case report[J].Clin Neuropharmacol,2021,44(6):235-237.DOI:10.1097/WNF.0000000000000476.
[29]
Tee CK, Suzaily W. Unremitting body odour: a case of olfactory reference syndrome[J].Clin Ter,2015,166(2):72-73.DOI:10.7417/CT.2015.1819.
[30]
Michael S,Boulton M,Andrews G.Two cases of olfactory reference syndrome responding to an atypical antipsychotic and SSRI[J].Aust N Z J Psychiatry,2014,48(9):878-879.DOI:10.1177/0004867414526791.
[31]
Li Z, Xiong Z, Jiang X, et al. Hiccups induced by aripiprazole combined with sertraline in an adolescent with olfactory reference disorder:a case report[J].Front Psychiatry,2022(13):793716.DOI:10.3389/fpsyt.2022.793716.
[32]
Jegede O, Virk I, Cherukupally K, et al. Olfactory reference syndrome with suicidal attempt treated with pimozide and fluvoxamine[J].Case Rep Psychiatry,2018(2018):7876497.DOI:10.1155/2018/7876497.
[33]
Muffatti R,Scarone S,Gambini O.An olfactory reference syndrome successfully treated by aripiprazole augmentation of antidepressant therapy[J].Cogn Behav Neurol,2008,21(4):258-260.DOI:10.1097/WNN.0b013e318185e6bd.
[34]
Thomas E,Voges J,Chiliza B,et al.Sniffing out olfactory reference syndrome[J].S Afr J Psychiatr,2017(23):1016.DOI:10.4102/sajpsychiatry.v23.1016.
[35]
Bezek Özsoy D,Ertekin E,Tükel R.Is olfactory reference syndrome a diagnostic entity under obsessive-compulsive and related disorders?A case report[J].Turk Psikiyatri Derg,2021,32(2):142-144.DOI:10.5080/u25129.
[36]
Vani P,Arumugam SS.The onerous odor:treating a case of olfactory reference syndrome with exposure-based cognitive behavior therapy[J].Asian J Psychiatr,2020(54):102264.DOI:10.1016/j.ajp.2020.102264.
[37]
Zantvoord JB,Vulink N,Denys D.Cognitive behavioral therapy for olfactory reference syndrome:a case report[J].J Clin Psychiatry,2016,77(9):e1144.DOI:10.4088/JCP.15cr10451.
[38]
Lim L,Wan YM.Jikoshu kyofu in Singapore[J].Australas Psychiatry,2015,23(3):300-302.DOI:10.1177/1039856215579541.
[1] 陈茵, 谭莹, 谭渤瀚, 何冠南, 王磊, 温昕, 朱巧珍, 梁博诚, 李胜利. 基于YOLO V8 的胎儿脐膨出超声智能质量评估与诊断[J/OL]. 中华医学超声杂志(电子版), 2025, 22(04): 305-310.
[2] 谢宛辰, 殷雪东, 李山奇, 李欣宇, 厉红元, 任国胜. 非特异性乳腺炎的诊疗进展[J/OL]. 中华乳腺病杂志(电子版), 2025, 19(02): 119-124.
[3] 谢挺. 创面诊断[J/OL]. 中华损伤与修复杂志(电子版), 2025, 20(03): 276-276.
[4] 唐浩然, 周彪, 巴特, 李洋洋. 严重烧伤后脓毒症早期诊断相关生物标记物的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2025, 20(01): 70-74.
[5] 曹亚玲, 房忠军, 徐玲, 姜彬彬, 张向颖, 黄晶, 任锋. 基于重组酶介导等温扩增技术-规律间隔成簇短回文重复序列/相关蛋白系统检测肺炎克雷伯菌方法的建立及评价[J/OL]. 中华实验和临床感染病杂志(电子版), 2025, 19(02): 70-76.
[6] 李晨曦, 龚忠诚, 张新华, 艾尔希丁·吐尔孙, 张璐. 罕见单侧完全性唇裂伴上颌骨复制畸形1例及文献系统综述[J/OL]. 中华口腔医学研究杂志(电子版), 2025, 19(02): 119-123.
[7] 阳敏, 廖江秀, 章国智, 张晔, 范林军. 常规超声联合临床特征对甲状腺微小乳头状癌中央区淋巴结转移的术前诊断价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 396-400.
[8] 黄世旺, 郄云凯, 胡海龙. 人工智能时代尿液无创检测方法在膀胱癌诊断中的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(03): 283-287.
[9] 丁强, 董翔, 甘卫东. TFE3 重排型肾细胞癌与肾透明细胞癌基于动态增强CT 和临床特征的鉴别[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(03): 329-334.
[10] 游通, 黄渝茹, 刘英, 罗兴艳, 罗琴. 慢性阻塞性肺疾病缓解期规律与不规律药物使用对疗效的影响分析[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(02): 321-325.
[11] 中国研究型医院学会肝胆胰外科专业委员会, 《中华消化外科杂志》编辑委员会. 肝门部胆管癌诊断和治疗指南(2025版)[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(03): 317-337.
[12] 刘立民, 张宗明, 赵月, 张翀, 刘卓, 齐晖. 医源性胆管损伤防治进展与现状[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(03): 346-353.
[13] 张翀, 张宗明, 刘卓, 刘立民, 赵月, 齐晖. 肝门部胆管癌诊治进展[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 167-180.
[14] 鲍文海, 阮勤, 李菲菲. Th17/Treg 免疫失衡在儿童腹型过敏性紫癜诊断与病情评估中的应用[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(02): 162-167.
[15] 孙柏平, 徐心, 徐泉, 贺译平, 张娟娟, 董晋. 妊娠合并自发性脾破裂临床研究[J/OL]. 中华产科急救电子杂志, 2025, 14(02): 102-105.
阅读次数
全文
10
HTML PDF
最新录用 在线预览 正式出版 最新录用 在线预览 正式出版
0 0 2 0 0 8

  来源 本网站 其他网站
  次数 8 2
  比例 80% 20%

摘要
36
最新录用 在线预览 正式出版
0 0 36
  来源 本网站 其他网站
  次数 13 23
  比例 36% 64%


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?